|
SLC25A30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8480000000265E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.10820000004597E-06 |
| Normal-vs-Stage2 |
1.471010E-01 |
| Normal-vs-Stage3 |
7.836800E-03 |
| Normal-vs-Stage4 |
3.214400E-02 |
| Stage1-vs-Stage2 |
4.090200E-01 |
| Stage1-vs-Stage3 |
9.602600E-01 |
| Stage1-vs-Stage4 |
8.195200E-01 |
| Stage2-vs-Stage3 |
5.098000E-01 |
| Stage2-vs-Stage4 |
4.574000E-01 |
| Stage3-vs-Stage4 |
8.015800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.59038999999472E-05 |
| Normal-vs-AfricanAmerican |
2.407500E-02 |
| Normal-vs-Asian |
1.401230E-01 |
| Caucasian-vs-AfricanAmerican |
5.372400E-01 |
| Caucasian-vs-Asian |
7.594200E-01 |
| AfricanAmerican-vs-Asian |
6.461400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.52590000529673E-08 |
| Normal-vs-Female |
1.848190E-01 |
| Male-vs-Female |
7.517500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.00949999998412E-06 |
| Normal-vs-Extreme_Weight |
7.76749997655202E-10 |
| Normal-vs-Obese |
1.328990E-01 |
| Normal-vs-Extreme_Obese |
9.925400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.826000E-01 |
| Normal_Weight-vs-Obese |
3.793800E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.204000E-01 |
| Extreme_Weight-vs-Obese |
5.536600E-03 |
| Extreme_Weight-vs-Extreme_Obese |
1.742400E-01 |
| Obese-vs-Extreme_Obese |
5.362600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.841670E-03 |
| Normal-vs-Age(41-60Yrs) |
3.608500E-04 |
| Normal-vs-Age(61-80Yrs) |
1.187790E-04 |
| Normal-vs-Age(81-100Yrs) |
1.831620E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.228800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.676000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.812000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.561400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.201000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.496400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.59790000412386E-09 |
| Normal-VS-Type2 PRCC |
6.316200E-01 |
| Normal-VS-KIRP CIMP |
1.09309999996032E-06 |
| Normal-VS-Unclassified PRCC |
3.052600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.048100E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.550800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.292370E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.372200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
4.587400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.951600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.392200E-02 |
| Normal-vs-N1 |
1.556200E-01 |
| Normal-vs-N2 |
6.386000E-04 |
| N0-vs-N1 |
6.815800E-01 |
| N0-vs-N2 |
4.564800E-01 |
| N1-vs-N2 |
3.276400E-01 |
|
|
